• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

    6.615 +0.045 (+0.68%)
    Streaming Delayed Price Updated: 11:11 AM EST, Jan 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 137,958
    Open 6.600
    Bid (Size) 6.610 (300)
    Ask (Size) 6.620 (300)
    Prev. Close 6.570
    Today's Range 6.510 - 6.700
    52wk Range 3.760 - 15.47
    Shares Outstanding 93,100,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference
    From Myriad Genetics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +7.7%
    +7.7%
    1 Month
    -5.4%
    -5.4%
    3 Month
    -15.6%
    -15.6%
    6 Month
    +26.7%
    +26.7%
    1 Year
    -53.7%
    -53.7%

    More News

    Read More
    News headline image
    3 Stocks Under $10 We Think Twice About
    Via StockStory
    News headline image
    3 Unprofitable Stocks That Fall Short
    Via StockStory
    News headline image
    Myriad Genetics (MYGN) Stock Trades Up, Here Is Why
    Via StockStory
    News headline image
    Why Myriad Genetics (MYGN) Stock Is Up Today
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q3 Earnings?
    Via StockStory
    Topics Stocks
    News headline image
    1 Healthcare Stock with Promising Prospects and 2 We Question
    Via StockStory
    Topics Economy Stocks
    News headline image
    Why Myriad Genetics (MYGN) Stock Is Trading Lower Today
    Via StockStory
    Topics Government
    News headline image
    Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    Myriad Genetics, Neogen, ICU Medical, HCA Healthcare, and Universal Health Services Stocks Trade Up, What You Need To Know
    Via StockStory
    Topics Economy Government
    News headline image
    Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    Why Myriad Genetics (MYGN) Stock Is Up Today
    Via StockStory
    Topics Artificial Intelligence Stocks
    News headline image
    Q3 Earnings Roundup: Myriad Genetics (NASDAQ:MYGN) And The Rest Of The Therapeutics Segment
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    1 High-Flying Stock with Solid Fundamentals and 2 We Question
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know
    Via StockStory
    Topics Artificial Intelligence Stocks
    News headline image
    Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    The Top 5 Analyst Questions From Myriad Genetics’s Q3 Earnings Call
    Via StockStory
    Topics Earnings
    News headline image
    Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Why Myriad Genetics (MYGN) Stock Is Down Today
    Via StockStory
    Topics Economy Government World Trade
    News headline image
    MYGN Q3 Deep Dive: Oncology Growth and Product Launches Offset Market Headwinds
    Via StockStory
    News headline image
    Myriad Genetics’s (NASDAQ:MYGN) Q3 Earnings Results: Revenue In Line With Expectations But Stock Drops
    Via StockStory

    Frequently Asked Questions

    Is Myriad Genetics, Inc. - Common Stock publicly traded?
    Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.
    What exchange does Myriad Genetics, Inc. - Common Stock trade on?
    Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?
    The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market
    What is the current price of Myriad Genetics, Inc. - Common Stock?
    The current price of Myriad Genetics, Inc. - Common Stock is 6.615
    When was Myriad Genetics, Inc. - Common Stock last traded?
    The last trade of Myriad Genetics, Inc. - Common Stock was at 01/13/26 11:11 AM ET
    What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
    The market capitalization of Myriad Genetics, Inc. - Common Stock is 615.86M
    How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
    Myriad Genetics, Inc. - Common Stock has 616M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.